由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Biology版 - Don't censor life-saving science
相关主题
求投病毒学文章的建议和意见, 感谢PLoS Pathogens审稿也太慢了点了吧
中医还是很牛的!point mutation
where to buy cancer cell inesDNA SEQUENCE的问题
求德文文献:-)由鱼想到的(欢迎讨论)
问个做HIV的问题Help with one atrial fibrillation mutation
Quick change mutated 4 bp at the same time?看Fig3~~~
amino acid substitution 是怎么个原则?问大家一个问题:关于野生型P53表达的
请问PLOS Pathogens审稿速度如何?What's called somatic mutation?
相关话题的讨论汇总
话题: virus话题: flu话题: h5n1话题: nsabb话题: more
进入Biology版参与讨论
1 (共1页)
r*****t
发帖数: 4793
1
Don't censor life-saving science
Controlling who is allowed access to information about mutations in the H5N1
bird flu virus is unacceptable, says Peter Palese21.
11 January 2012
Article toolsPrint
Email
Download PDF
Rights and Permissions
Share/bookmark
Connotea
Facebook
Delicious
Twitter
Digg
Friendfeed
The recent arguments over the creation of a transmissible form of the bird
flu virus (H5N1) feel very familiar. My colleagues and I were at the centre
of a similar controversy in 2005, when we reconstructed the 1918 flu virus,
which had killed up to 50 million people worldwide. News stories around the
globe debated the merits of our research and television pundits argued
opposing viewpoints. Naturally, the US government was concerned — as it is
now. Yet our research was published in full. So why are similar concerns
being used now to demand unacceptable censorship of the H5N1 scientific
papers?
I have spent my career studying potentially dangerous pathogens — 20 years
ago, my lab developed the technique that has enabled the H5N1 researchers to
insert the mutations that render the virus more easily transmissible. In
the 1990s, researchers discovered degraded samples of the 1918 virus in lung
tissue from US soldiers who had died from the 'Spanish flu'. Using
polymerase chain reaction technology, they amplified and sequenced the virus
's RNA. We then took an existing influenza virus and, one by one, swapped
its genes with those from the 1918 virus, eventually recreating a live
version.
As we prepared our results for publication, the US government convened the
National Science Advisory Board for Biosecurity (NSABB), which advises the
community about research using agents that pose threats to national security
or public health. Our experiments had made some people nervous.
Related content
Call to censor flu studies draws fire
Fears grow over lab-bred flu
The 1918 flu virus is resurrected
During our discussions with members of the NSABB, we explained the
importance of bringing such a deadly pathogen back to life. Although these
experiments may seem dangerously foolhardy, they are actually the exact
opposite. They gave us the opportunity to make the world safer, allowing us
to learn what makes the virus dangerous and how it can be disabled.
Thankfully, the discussions were largely constructive — within a week, the
NSABB recommended that we continue to study the virus under biocontainment
conditions, and publish the results so that other scientists could
participate in the research. After we published our full paper in 2005 (T. M
. Tumpey et al. Science 310, 77–80; 2005), researchers poured into the
field who probably would not otherwise have done, leading to hundreds of
papers about the 1918 virus. As a result, we now know that the virus is
sensitive to the seasonal flu vaccine, as well as to the common flu drugs
amantadine (Symmetrel) and oseltamivir (Tamiflu). Had we not reconstructed
the virus and shared our results with the community, we would still be in
fear that a nefarious scientist would recreate the Spanish flu and release
it on an unprotected world. We now know such a worst-case scenario is no
longer possible.
This experience has made the NSABB's latest recommendation — that the H5N1
researchers not reveal the mutations behind the virus's transmissibility —
all the more frustrating. I make the same argument today that we made in
2005 — publishing those experiments without the details is akin to
censorship, and counter to science, progress and public health. Why did the
(different) members of the committee come to a different conclusion in this
case? I can only hope that they take a more sensible stance and change their
minds, or that the scientific community at large convinces them to do so.
Certainly, the authors of the papers, as well as the journals considering
them for publication (including this one), should resist the committee's
unworkable compromise that the full information should be released only to
approved experts, and insist on full disclosure.
Giving the full details to vetted scientists is neither practical nor
sufficient. Once 20–30 laboratories with postdoctoral fellows and students
have such information available, it will be impossible to keep the details
secret. Even more troublesome, however, is the question of who should decide
which scientists are allowed to have the information. We need more people
to study this potentially dangerous pathogen, but who will want to enter a
field in which you can't publish your most scientifically interesting
results?
“Who will want to enter a field in which you can't publish your most
scientifically interesting results?”
Knowing which mutations render the virus more dangerous could help on a
public-health level — if an outbreak of bird flu occurs in Taiwan, for
instance, and researchers sequence the virus and see those mutations, we
would know to ramp up the production of appropriate vaccines and antiviral
drugs.
Incidentally, I believe that the risk of future outbreaks in humans is low:
H5N1 has had the opportunity to cause widespread pandemics for many, many
decades, yet it has not done so. Although we know the virus is transmissible
between ferrets, little is known about how it will behave in other animals,
including humans.
The more danger a pathogen poses, the more important it is to study it (
under appropriate containment conditions), and to share the results with the
scientific community. Slowing down the scientific enterprise will not '
protect' the public — it only makes us more vulnerable.
Journal name:
Nature
Volume:
481,
Pages:
115
Date published:
(12 January 2012)
DOI:
doi:10.1038/481115a
Editor's note: Nature is considering one of the papers and the NSABB's
recommendations. It is also involved in consultations about how restricted
access to the scientific methods and data might be implemented.
1 (共1页)
进入Biology版参与讨论
相关主题
What's called somatic mutation?问个做HIV的问题
scientific support of "其实,那些四十几以上的男人不应该执Quick change mutated 4 bp at the same time?
某个基因的mutation analysis,200个病人样本,请问什么方法比较好amino acid substitution 是怎么个原则?
disease mutation database?请问PLOS Pathogens审稿速度如何?
求投病毒学文章的建议和意见, 感谢PLoS Pathogens审稿也太慢了点了吧
中医还是很牛的!point mutation
where to buy cancer cell inesDNA SEQUENCE的问题
求德文文献:-)由鱼想到的(欢迎讨论)
相关话题的讨论汇总
话题: virus话题: flu话题: h5n1话题: nsabb话题: more